JW Pharma ApS: Financial statements 2020
CVR: 39330563
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
JW Pharma ApS (CVR 39330563) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 69,536 and a net result of DKK 69,390 compared with DKK -125,020 the year before. Equity in the 2020 report amounted to DKK -92,383.
- Gross Profit
- DKK 69,536
- Profit/Loss
- DKK 69,390
- Equity
- DKK -92,383
- Total Assets
- DKK 346,886
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 70 t. | 69 t. | -92 t. | - |
| 2019 | - | -125 t. | -125 t. | -162 t. | - |
| 2018 | - | -85 t. | -87 t. | -37 t. | - |
Official annual report
How creditworthy is JW Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
JW Pharma ApS has published its annual report for 2019. Gross profit came to DKK -125,017, and the net result was DKK -125,020.
About JW Pharma ApS
JW Pharma ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 27 October 2025. The company was registered under the industry Detailhandel med andre fødevarer. In 2024, the company reported a gross profit of DKK -5,857 and a net result of DKK -5,857 compared with DKK -4,637 the year before. Equity in the 2024 report amounted to DKK -147,099.